Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.246x

Shaanxi Meibang Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a cash flow conversion efficiency ratio of 0.246x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥281.88 Million ≈ $41.25 Million USD) by net assets (CN¥1.15 Billion ≈ $167.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

Cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Shaanxi Meibang Pharmaceutical Group Co for real-time trading data and today's change.

Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Shaanxi Meibang Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see Shaanxi Meibang Pharmaceutical Group Co stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
BlackRock TCP Capital Corp NASDAQ:TCPC	0.386x
Suzhou Institute of Building Science Group Co Ltd SHG:603183	-0.004x
Danhua Chemical Technology Co Ltd A SHG:600844	0.073x
Gevo Inc NASDAQ:GEVO	-0.105x
EVN Finance JSC VN:EVF	-0.148x
Gran Tierra Energy Inc TO:GTE	0.426x
Hollyland China Electronics Technology Corp Ltd SHE:002729	0.036x
Shenzhen Longli Technology Co Ltd Class A SHE:300752	0.018x

Annual Cash Flow Conversion Efficiency for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. Review how much free cash does Shaanxi Meibang Pharmaceutical Group Co generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.12 Billion ≈ $164.57 Million	CN¥280.40 Million ≈ $41.03 Million	0.249x	-17.03%
2023-12-31	CN¥1.11 Billion ≈ $163.04 Million	CN¥334.79 Million ≈ $48.99 Million	0.300x	+158.23%
2022-12-31	CN¥1.09 Billion ≈ $158.97 Million	CN¥126.41 Million ≈ $18.50 Million	0.116x	+203.46%
2021-12-31	CN¥966.95 Million ≈ $141.50 Million	CN¥-108.75 Million ≈ $-15.91 Million	-0.112x	-167.50%
2020-12-31	CN¥449.37 Million ≈ $65.76 Million	CN¥74.88 Million ≈ $10.96 Million	0.167x	-51.92%
2019-12-31	CN¥370.63 Million ≈ $54.24 Million	CN¥128.45 Million ≈ $18.80 Million	0.347x	+464.79%
2018-12-31	CN¥276.37 Million ≈ $40.44 Million	CN¥16.96 Million ≈ $2.48 Million	0.061x	-62.35%
2017-12-31	CN¥180.43 Million ≈ $26.40 Million	CN¥29.41 Million ≈ $4.30 Million	0.163x	--

About Shaanxi Meibang Pharmaceutical Group Co Ltd

SHG:605033 China Agricultural Inputs

Market Cap

$338.11 Million

CN¥2.31 Billion CNY

Market Cap Rank

#13938 Global

#4139 in China

Share Price

CN¥17.09

Change (1 day)

-0.52%

52-Week Range

CN¥16.11 - CN¥31.54

All Time High

CN¥31.54